Search results
Moderna (MRNA) Seeks FDA Nod for Omicron-Based COVID Jab
Zacks via Yahoo Finance· 2 years agoModerna's (MRNA) bivalent COVID-19 booster vaccine, mRNA-1273.222, is designed to target the Omicron...
Moderna's (MRNA) Omicron Based Jab gets Approval in Australia
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) receives provisional approval in Australia for its Omicron-containing bivalent...
Moderna (MRNA) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 10 months agoModerna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. The company...
Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal
Zacks via Yahoo Finance· 1 year agoShares of Moderna MRNA were up 4.6% after management announced that the phase II/III study...
Moderna's (MRNA) COVID Jab Gets Nod For Kids in Canada
Zacks via Yahoo Finance· 2 years agoModerna MRNA received approval from Canadian regulatory authority, Health Canada, for its mRNA...
Biotech Stock Roundup: MRNA's Vaccine Update, AMGN & HZNP Clear FTC Lawsuit & More
Zacks via Yahoo Finance· 8 months agoIt was a busy week for the biotech sector, with quite a few important regulatory and pipeline...
Can Moderna (MRNA) Diversify Beyond Its COVID-19 Jab Sales?
Zacks via Yahoo Finance· 9 months agoWith COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its...
Moderna (MRNA) Updated COVID Jab Effective Against Pirola Variant
Zacks via Yahoo Finance· 8 months agoClinical study data shows Moderna's (MRNA) updated COVID-19 vaccine generates a robust immune...
Biotech Stock Roundup: GILD's Drug News, NVAX & MRNA COVID-19 Vaccine Updates
Zacks via Yahoo Finance· 2 years agoWith the end of Q2 earnings, the focus is on pipeline and regulatory updates in the biotech sector....
Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program
Zacks via Yahoo Finance· 2 years agoModerna, Inc. MRNA reported earnings of $5.24 per share for the second quarter of 2022, beating the...